Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Mayo Clinic
German CLL Study Group
European Organisation for Research and Treatment of Cancer - EORTC